First National Bank of Omaha lowered its position in Analogic Corporation (NASDAQ:ALOG) by 1.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,636 shares of the medical research company’s stock after selling 245 shares during the period. First National Bank of Omaha owned approximately 0.11% of Analogic Corporation worth $991,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in ALOG. SG Americas Securities LLC purchased a new position in shares of Analogic Corporation during the first quarter valued at about $101,000. State of Alaska Department of Revenue boosted its position in shares of Analogic Corporation by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 1,380 shares of the medical research company’s stock valued at $104,000 after buying an additional 40 shares during the period. US Bancorp DE boosted its position in shares of Analogic Corporation by 59.0% in the first quarter. US Bancorp DE now owns 1,635 shares of the medical research company’s stock valued at $124,000 after buying an additional 607 shares during the period. Dubuque Bank & Trust Co. purchased a new position in shares of Analogic Corporation during the first quarter valued at about $185,000. Finally, Municipal Employees Retirement System of Michigan raised its stake in shares of Analogic Corporation by 2.5% in the first quarter. Municipal Employees Retirement System of Michigan now owns 2,850 shares of the medical research company’s stock valued at $216,000 after buying an additional 70 shares in the last quarter.

Analogic Corporation (ALOG) opened at 70.65 on Wednesday. Analogic Corporation has a one year low of $66.00 and a one year high of $95.85. The firm’s market capitalization is $881.01 million. The stock’s 50 day moving average price is $70.57 and its 200-day moving average price is $73.85.

Analogic Corporation (NASDAQ:ALOG) last released its quarterly earnings results on Tuesday, June 6th. The medical research company reported $0.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.05. Analogic Corporation had a negative net margin of 7.97% and a positive return on equity of 6.75%. The company had revenue of $122.16 million during the quarter, compared to the consensus estimate of $121.35 million. During the same period in the prior year, the firm earned $0.80 earnings per share. Analogic Corporation’s revenue was down 4.5% on a year-over-year basis. On average, equities research analysts anticipate that Analogic Corporation will post $2.62 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/09/first-national-bank-of-omaha-has-991000-stake-in-analogic-corporation-alog-updated-updated.html.

About Analogic Corporation

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Institutional Ownership by Quarter for Analogic Corporation (NASDAQ:ALOG)

Receive News & Stock Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related stocks with our FREE daily email newsletter.